A. Zlotta - Concepedia

Author

A. Zlotta

University Health Network

Also Known As

A R Zlotta, A Zlotta, A. Zlotta, A.R Zlotta, A.R. Zlotta, ALEX ZLOTTA, Alex Zlotta, Zlotta, A, Zlotta, Alexandre

Publications

829

Citations

H-Index

Concepts

All Affiliations

University Health Network University of Toronto Lunenfeld-Tanenbaum Research Institute University of Vienna

About

A. Zlotta is an author at University Health Network specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	121
2	Pathology	2	2	72
3	Surgical Oncology	1	1	59
4	Cancer Genetics	1	1	59
5	Tumor Biology	1	1	59

A. Zlotta

Publications

695

Citations

H-Index

Page 1

	Year	Citations
PROSPECTIVE EVALUATION OF PROSTATE CANCER DETECTED ON BIOPSIES 1, 2, 3 AND 4: WHEN SHOULD WE STOP? Bob Djavan, V. Ravery, A. Zlotta, The Journal of Urology	2001	447
Pathological features of prostate cancer detected on initial and repeat prostate biopsy: Results of the prospective European prostate cancer detection study Bob Djavan, Peter Mazal, A. Zlotta, The Prostate	2001	92
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment Damien Pouessel, Y. Neuzillet, Laura S. Mertens, Annals of Oncology UrologySurgical OncologyGenitourinary CancerTumor HeterogeneityMedicine	2016	59
Expert Opinion on Optimal Testosterone Control in Prostate Cancer A. Zlotta, F.M.J. Debruyne European Urology Supplements UrologyAndrologyExpert OpinionMedicineProstatic Disease	2005	49
The Prostate Cancer Rehabilitation Clinic: A Biopsychosocial Clinic for Sexual Dysfunction after Radical Prostatectomy A. Matthew, Noga Lutzky-Cohen, Leah Jamnicky, Current Oncology	2018	25
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture Renu Jeyapala, Andrea J. Savio, Ekaterina Olkhov‐Mitsel, European Urology Oncology Prognostic BiomarkersUrologyOncologyBiochemical RecurrenceGenitourinary Cancer	2018	13
Improving patient journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological Association- Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting Wassim Kassouf, Armen Aprikian, Fred Saad, Canadian Urological Association Journal	2018	10

Page 1